Identification and Development of Therapeutics for COVID-19

  • Halie M. Rando
    Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Nils Wellhausen
    Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Soumita Ghosh
    Institute of Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Alexandra J. Lee
    Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Anna Ada Dattoli
    Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Fengling Hu
    Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • James Brian Byrd
    University of Michigan School of Medicine, Ann Arbor, Michigan, USA
  • Diane N. Rafizadeh
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Ronan Lordan
    Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Yanjun Qi
    Department of Computer Science, University of Virginia, Charlottesville, Virginia, USA
  • Yuchen Sun
    Department of Computer Science, University of Virginia, Charlottesville, Virginia, USA
  • Christian Brueffer
    Department of Clinical Sciences, Lund University, Lund, Sweden
  • Jeffrey M. Field
    Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Marouen Ben Guebila
    Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
  • Nafisa M. Jadavji
    Biomedical Science, Midwestern University, Glendale, Arizona, USA
  • Ashwin N. Skelly
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Bharath Ramsundar
    The DeepChem Project
  • Jinhui Wang
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Rishi Raj Goel
    Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
  • YoSon Park
    Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Simina M. Boca
    Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA
  • Anthony Gitter
    Department of Biostatistics and Medical Informatics, University of Wisconsin—Madison, Madison, Wisconsin, USA
  • Casey S. Greene
    Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA

抄録

<jats:p>The COVID-19 pandemic is a rapidly evolving crisis. With the worldwide scientific community shifting focus onto the SARS-CoV-2 virus and COVID-19, a large number of possible pharmaceutical approaches for treatment and prevention have been proposed.</jats:p>

収録刊行物

  • mSystems

    mSystems 6 (6), 2021-12-21

    American Society for Microbiology

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ